| Labiris, Georgios |
NCT04739137: Smart-TV Application for the Self Examination of the Distance Visual Acuity in Macular Edema Patients |
|
|
| Active, not recruiting | N/A | 300 | Europe | DDiVAT Testing, Distance visual acuity assessment via ETDRS chart | Democritus University of Thrace | Low Vision, Macular Edema, Refractive Errors | 08/21 | 09/21 | | |
NCT05209581: Assessment of Visual Acuity in Refugee Population |
|
|
| Completed | N/A | 330 | Europe | Distance Visual Acuity Examination | Democritus University of Thrace | Visual Acuity, Refractive Errors, Low Vision, Vision Disorders | 04/22 | 05/22 | | |
| Recruiting | N/A | 300 | Europe | DDVIT testing, ETDRS testing | Democritus University of Thrace, University of Thessaly | Refractive Errors, Low Vision, Vision Disorders | 05/22 | 06/22 | | |
NCT05359380: The Impact of Light Conditions on the Efficacy of Multifocal Intraocular Lens Implantation in Activities of Daily Living |
|
|
| Completed | N/A | 75 | Europe | ADL performance | Democritus University of Thrace | Presbyopia, Near Vision, Reading, Daily Activities, Multifocal Intraocular Lens, Cataract | 07/22 | 09/22 | | |
NCT05494177: Comparison of Premium Monovision and Bilateral Implantation of Trifocal Diffractive Intraocular Lenses |
|
|
| Completed | N/A | 100 | Europe | bUDVA, bUIRA, bUNRA, bUICPS, bUNCPS, Contrast sensitivity | Democritus University of Thrace | Presbyopia, Refractive Errors, Cataract | 12/22 | 03/23 | | |
NCT05319470: Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives |
|
|
| Completed | N/A | 25 | Europe | Intraocular pressure (IOP), Tear Break-up Time (TBUT), Conjuctival Hyperemia, Schirmer Test, Visual Fields and OCT RNFL | Democritus University of Thrace | Glaucoma, Glaucoma; Drugs, Ocular Surface Disease | 04/23 | 05/23 | | |
NCT05835193: Pre-symptomatic Screening of Visual Acuity in Pre-school Students |
|
|
| Completed | N/A | 1098 | Europe | Diagnostic Test: Distance Visual Acuity Examination | Democritus University of Thrace | Visual Acuity, Refractive Errors, Low Vision, Vision Disorders | 06/23 | 06/23 | | |
NCT05411341: Comparison of Two Different Optical Biometric Systems |
|
|
| Recruiting | N/A | 100 | Europe | Argos (Alcon Laboratories, Inc.), IOLMaster 500 (Carl Zeiss Meditec AG) | Democritus University of Thrace | Cataract, Presbyopia, Ocular Biometry, Intraocular Lens | 07/24 | 08/24 | | |
NCT06460389: Visual Outcomes After Extended Depth of Focus Intraocular Lens Implantation with and Without Digital Assistance |
|
|
| Recruiting | N/A | 60 | Europe | Visual Acuity Assessment | Democritus University of Thrace | Presbyopia, Pseudophakia, Cataract, Refractive Errors | 11/24 | 01/25 | | |
| Recruiting | N/A | 100 | Europe | Short video and Questionnaire | Democritus University of Thrace | Sleep Apnea Syndrome, Obstructive, Drowsiness, Blinking, Concentration Ability Impaired, Pupil Diameter | 02/24 | 07/24 | | |
NCT06260852: Identification of Minimum Focal Points in Vision Curve Formation |
|
|
| Recruiting | N/A | 80 | Europe | Diagnostic Test: Visual Acuity Assessment | Democritus University of Thrace | Presbyopia, Pseudophakia, Cataract, Refractive Errors | 08/24 | 08/24 | | |
NCT04632901: A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA) |
|
|
| Recruiting | N/A | 300 | Europe | VA assessment, CVA assessment | Democritus University of Thrace | Visual Acuity | 01/21 | 02/21 | | |
NCT04733014: Perceptions of Ophthalmologists Regarding Contemporary Presbyopia Management. |
|
|
| Recruiting | N/A | 200 | Europe | | Democritus University of Thrace | Presbyopia | 02/21 | 02/21 | | |
NCT04739085: Level of Agreement Between Clinical Defocus Curves and the Web-based Democritus Digital Acuity Reading Test wDDART |
|
|
| Recruiting | N/A | 100 | Europe | Defocus curves - Monocular distance visual acuity with trial lenses added to the best correction for distance, wDDART - Monocular near visual acuity using the best correction for distance | Democritus University of Thrace | Presbyopia, Near Vision | 03/21 | 05/21 | | |
| Froudarakis, Marios E |
| Withdrawn | 2b | 250 | Europe | DILTIAZEM TEVA 60 mg or placebo | Hospices Civils de Lyon, Signia Therapeutics | COVID-19 | 10/24 | 12/24 | | |
| Kakolyris, Stylianos |
NCT04480814: Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC |
|
|
| Active, not recruiting | N/A | 120 | Europe | PIK3CA kit | Pharmassist Ltd, University of Athens | Breast Cancer | 05/23 | 06/23 | | |
NCT04490564: Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma |
|
|
| Active, not recruiting | N/A | 185 | Europe | PD-L1 Kit | Pharmassist Ltd, University of Athens | Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer, Melanoma | 05/23 | 06/23 | | |
| Papagoras, Charalampos |
RESOLUTION-1, NCT05516758: A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis |
|
|
| Completed | 2 | 491 | Europe, Canada, Japan, US, RoW | Peresolimab, Placebo | Eli Lilly and Company | Rheumatoid Arthritis, Arthritis, Joint Diseases, Musculoskeletal Diseases, Rheumatic Diseases, Connective Tissue Diseases, Autoimmune Diseases, Immune System Diseases | 11/23 | 01/25 | | |
| Gjurasin, Branimir |
| Completed | N/A | 160 | RoW | Evaluation of the degree of fibrosis and steatosis, Screening for the components of metabolic syndrome, Measurement of serum semaphorin concentrations, Identification of semaphorin gene polymorphisms | University Hospital for Infectious Diseases, Croatia, Croatian Science Foundation | Non-Alcoholic Fatty Liver Disease, Immune Response, Biomarkers, Liver Fibrosis, Non Alcoholic Steatohepatitis | 09/21 | 03/22 | | |
| Recruiting | N/A | 160 | RoW | Evaluation of the degree of steatosis, Screening for the components of metabolic syndrome, Measurement of serum semaphorin concentrations, Measurement of inflammatory cytokines | University Hospital for Infectious Diseases, Croatia, Croatian Science Foundation | Steatosis of Liver, Sepsis, Immune Response | 02/24 | 03/24 | | |
| Recruiting | N/A | 20000 | Europe, RoW | VAP | European Clinical Research Alliance for Infectious Diseases (ECRAID), Centre Hospitalier Universitaire Dupuytren de Limoges (CHUL), Université de Genève (UNIGE), University Medical Center Utrecht (UMCU) | Ventilator Associated Pneumonia | 12/25 | 03/26 | | |
| Kotsianidis, Ioannis |
| Active, not recruiting | 3 | 430 | Europe, Canada, US, RoW | Pelabresib, Ruxolitinib, Placebo | Constellation Pharmaceuticals | Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis | 08/23 | 12/27 | | |
|
|
|
|
|
| Gavriilidis, Efstratios |
NCT05279391: Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19 |
|
|
| Recruiting | N/A | 150 | Europe | Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml Inj Syringe, Tocilizumab, Baricitinib, Dornase Alfa Inhalant Product | Democritus University of Thrace | COVID-19 Severe Respiratory Failure | 11/21 | 12/23 | | |
| Antoniadou, Christina |
NCT05279391: Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19 |
|
|
| Recruiting | N/A | 150 | Europe | Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml Inj Syringe, Tocilizumab, Baricitinib, Dornase Alfa Inhalant Product | Democritus University of Thrace | COVID-19 Severe Respiratory Failure | 11/21 | 12/23 | | |
| Ritis, Konstantinos |
NCT05279391: Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19 |
|
|
| Recruiting | N/A | 150 | Europe | Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml Inj Syringe, Tocilizumab, Baricitinib, Dornase Alfa Inhalant Product | Democritus University of Thrace | COVID-19 Severe Respiratory Failure | 11/21 | 12/23 | | |
| Spanoudakis |
MajesTEC-4, NCT05243797 / 2021-002531-27: Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation |
|
|
| Recruiting | 3 | 1594 | Europe, Canada, US, RoW | Teclistamab, JNJ-64007957, Lenalidomide | Stichting European Myeloma Network, Janssen Pharmaceutica | Multiple Myeloma | 04/28 | 04/32 | | |
TAURUS, NCT06189833: Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - |
|
|
| Recruiting | 2 | 200 | Europe | Daratumumab, JNJ-54767414, Bortezomib, Velcade, Lenalidomide, Dexamethasone | Stichting European Myeloma Network, Janssen Pharmaceutica | Multiple Myeloma | 12/24 | 12/25 | | |
